Mark Kaye
EVP & CFO at Elevance Health; EVP & Chief Financial Officer at Moody's; Director at CONMED. Based in Indianapolis, Indiana.
- Rank
- 8873rd of 14,644
- Companies held
- 3
- Largest holding
- ELV, 78.3% of total
- Latest SEC filing
- Oct 22, 2026
What the $9.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Elevance Health ELV Common Stock | Directly | 19,919 | $389.40 | $7.8M | 78.3% | Form 4, Oct 22, 2026 |
| Moody's MCO Common Stock | Directly | 4,447 | $473.87 | $2.1M | 21.3% | Form 4, Aug 7, 2023 |
| CONMED CNMD Common Stock | Directly | 820 | $46.79 | $38K | 0.4% | Form 4, Jun 2, 2026 |
Share counts are the amounts Mark Kaye reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Sold | ELV | 400 | $434.00 | $174K | View |
| Oct 22, 2026 | Sold | ELV | 321 | $435.25 | $140K | View |
| Oct 22, 2026 | Sold | ELV | 1,660 | $436.20 | $724K | View |
| Oct 22, 2026 | Sold | ELV | 560 | $437.07 | $245K | View |
| Oct 22, 2026 | Sold | ELV | 240 | $438.22 | $105K | View |
| Oct 22, 2026 | Sold | ELV | 1,160 | $439.25 | $510K | View |
| Oct 22, 2026 | Sold | ELV | 1,720 | $440.44 | $758K | View |
| Oct 22, 2026 | Sold | ELV | 2,343 | $441.34 | $1.0M | View |
| Oct 22, 2026 | Sold | ELV | 480 | $442.61 | $212K | View |
| Oct 22, 2026 | Sold | ELV | 440 | $443.81 | $195K | View |
| Oct 22, 2026 | Sold | ELV | 160 | $444.85 | $71K | View |
| Oct 22, 2026 | Sold | ELV | 827 | $446.05 | $369K | View |
| Oct 22, 2026 | Sold | ELV | 273 | $447.19 | $122K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8870 | Michael S. Frankel Director, Rexford Industrial Realty. Los Angeles, CA | $9.9M |
| 8871 | John Panikar Executive VP, APAC, Linde | $9.9M |
| 8872 | Mikael Dolsten President R&D, Pfizer. Santa Clara, CA | $9.9M |
| 8873 | Mark Kaye EVP & CFO, Elevance Health. Indianapolis, IN | $9.9M |
| 8874 | James M. Lucania EVP & CFO, HealthEquity. Draper, UT | $9.9M |
| 8875 | John Swallow President & CEO, Idaho Strategic Resources. Coeur D'Alene, ID | $9.9M |
| 8876 | Kenneth Bockhorst Chairman, President & CEO, Badger Meter. Atlanta, GA | $9.9M |
Other Elevance Health insiders
All ELV insiders- Gail Boudreaux$67.0MPresident and CEO. #2021 overall
- John E. Gallina$24.8MEVP & Chief Financial Officer. #4403 overall
- Gloria M. McCarthy$20.0MEVP & Chief Administrative Off. #5194 overall
- Felicia F. Norwood$15.1MEVP &Chief Health Benefits Ofr. #6269 overall
- Peter D. Haytaian$10.6MEVP & Pres Carelon & CarelonRx. #8435 overall
- Blair Williams Todt$6.1MEVP, CLO & CAO. #12668 overall
Questions
How much stock does Mark Kaye own?
Mark Kaye holds $9,902,023 in listed stock based on SEC filings and current prices, mostly Elevance Health (ELV). That ranks 8873rd on the Stock Rich List.
Is this Mark Kaye's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark Kaye last buy or sell stock?
The most recent open-market trade on file is a sale of 400 ELV shares on Oct 22, 2026 at $434.00.